World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
25566
World Ranking
17029
National Ranking
8541

Benjamin Movsas publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Benjamin Movsas sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 746 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Benjamin Movsas D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Benjamin Movsas sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Benjamin Movsas is affiliated with the Henry Ford Health System in the United States and has contributed extensively to the field of medicine, particularly in oncology and radiation therapy. Their body of work covers a range of topics related to advanced radiotherapy techniques, lung cancer diagnosis and treatment, and the application of radiomics and machine learning in medical imaging.

The main fields of study for Benjamin Movsas include Medicine with a focus on several subfields such as Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Radiation, and Molecular Biology. Their research topics emphasize:

  • Advanced Radiotherapy Techniques
  • Lung Cancer Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer survivorship and care
  • Head and Neck Cancer Studies
  • Lung Cancer Treatments and Mutations
  • Prostate Cancer Diagnosis and Treatment

Their frequent co-authors include Indrin J. Chetty, Farzan Siddiqui, Stephen L. Brown, Hassan Bagher-Ebadian, and Mohamed A. Elshaikh, reflecting collaborative efforts mainly within the radiation oncology domain.

Benjamin Movsas has published in several highly regarded venues, including:

  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • Practical Radiation Oncology
  • Medical Physics
  • Cancer Research

Selected recent publications highlight a range of clinical and translational research efforts:

  • Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine, 2023, JAMA Oncology
  • Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer, 2020, Molecular Therapy - Oncolytics
  • Evaluation of Auto-Contouring and Dose Distributions for Online Adaptive Radiation Therapy of Patients With Locally Advanced Lung Cancers, 2022, Practical Radiation Oncology
  • Therapeutic enhancement of radiation and immunomodulation by gold nanoparticles in triple negative breast cancer, 2021, Cancer Biology & Therapy
  • American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer, 2021, International Journal of Radiation Oncology*Biology*Physics

Best Publications

  • Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

    Walter J. Curran;Rebecca Paulus;Corey J. Langer;Ritsuko Komaki

  • Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

    Miljenko V. Pilepich;Kathryn Winter;Colleen A. Lawton;Robert E. Krisch

  • Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.

    William F. Harstell;Charles B. Scott;Deborah Watkins Bruner;Charles W. Scarantino

  • Treatment of Non-small Cell Lung Cancer Stage I and Stage II: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)

    Walter J. Scott;John Howington;Steven Feigenberg;Benjamin Movsas

  • Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions

    Gerald E Hanks;Alexandra L Hanlon;Timothy E Schultheiss;Wayne H Pinover

  • Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

    Alan Pollack;Gail Walker;Eric M. Horwitz;Robert Price

  • Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis

    Alexander Sun;Kyounghwa Bae;Elizabeth M. Gore;Benjamin Movsas

  • Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410

    W Curran;C Scott;C Langer;R Komaki

  • Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline

    Gregory M.M. Videtic;Jessica Donington;Meredith Giuliani;John Heinzerling

  • A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

    Kevin J. Murray;Charles Scott;Harvey M. Greenberg;Bahman Emami

  • Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline

    Charles M. Rudin;Nofisat Ismaila;Christine L. Hann;Narinder Malhotra

  • Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus.

    Feng-Ming Spring Kong;Timothy Ritter;Douglas J Quint;Suresh Senan

  • Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery†

    Samuel Ryu;Jian Yue Jin;Ryan Jin;Jack Rock

  • Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With Chemoradiation: An Analysis of the Radiation Therapy Oncology Group

    Mitchell Machtay;Kyounghwa Bae;Benjamin Movsas;Rebecca Paulus

  • Radiation Pulmonary Toxicity: From Mechanisms to Management

    Paul R. Graves;Farzan Siddiqui;Mitchell S. Anscher;Benjamin Movsas

  • RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results.

    Samuel Ryu;Stephanie L. Pugh;Peter C. Gerszten;Fang Fang Yin

  • Primary analysis of a phase II randomized trial radiation therapy Oncology Group (RTOG) 0212: Impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer

    Aaron H. Wolfson;Kyounghwa Bae;Ritsuko Komaki;Christina Meyers

  • Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial

    Alan Pollack;Alexandra L. Hanlon;Eric M. Horwitz;Steven J. Feigenberg

  • Randomized Trial of Amifostine in Locally Advanced Non–Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiation: Radiation Therapy Oncology Group Trial 98-01

    Benjamin Movsas;Charles Scott;Corey Langer;Maria Werner-Wasik

  • Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the α/β ratio

    Alan E Nahum;Benjamin Movsas;Eric M Horwitz;Corinne C Stobbe

Frequent Co-Authors

Corey J. Langer
Corey J. Langer University of Pennsylvania
Walter J. Curran
Walter J. Curran Emory University
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
Mei Lu
Mei Lu Henry Ford Health System
Larry L. Kestin
Larry L. Kestin Beaumont Health
Alexandra L. Hanlon
Alexandra L. Hanlon Virginia Tech
Lori J. Pierce
Lori J. Pierce University of Michigan–Ann Arbor
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
Alan Pollack
Alan Pollack University of Miami
Laurie E. Gaspar
Laurie E. Gaspar University of Colorado Denver

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA, numerous online programs offer flexible pathways toward healthcare careers. Many students begin with nursing degrees, which can be a more affordable and accessible entry point. For those looking to start their journey, there are affordable nursing programs online that provide a solid foundation in patient care and clinical skills.

Registered nurses seeking career advancement may consider bridging programs. The cheapest online rn to bsn programs allow practicing RNs to earn a bachelor’s degree quickly and affordably, opening doors to greater responsibility and higher salaries.

For those who aspire to leadership or academic roles, doctoral programs are available entirely online. Explore online phd programs nursing for affordable options to achieve top-level credentials without sacrificing current work commitments.

Non-nurses interested in entering the nursing profession can pursue msn direct entry programs online. These accelerated graduate programs are designed for those with a bachelor’s in another field and provide a fast track to becoming a registered nurse.

Best Scientists Citing Benjamin Movsas

Trending Scientists

Recently Published Articles